High Blood Cadmium Level in Short Sleepers: Results from the 2008–2013 Korean National Health and Nutrition Survey

The article's abstract is not available.

Accumulation of cadmium in organs of experimental animals and its effect on the content of essential elements in the chronic intoxication

Introduction. This article presents the results of studying the effects of cadmium chloride and its accumulation in experimental animals’ liver, kidneys, and blood. The impact of cadmium consumption on basic bioelements (zinc, copper, calcium) in organs was assessed. Materials and methods. Experimental groups of white outbred rats were exposed daily for three months to a cadmium chloride solution containing 1, 10 and 100 μg of cadmium. Cadmium exposure was assessed at 1, 4, 12, 30, 60 and 90 days. The concentrations of cadmium, calcium, copper and zinc were measured by atomic absorption spectrometry. Results. Whole blood cadmium concentration was not statistically different from the control group. The accumulation of cadmium in the blood was observed only after three months of exposure to a dose of 100 μg. The accumulation of cadmium in the liver occurred after one and two months of intoxication, depending on the dose. In the kidneys, an increase in cadmium occurred in all experimental groups after one month of injection. The metal content depended on the level of exposure, but no difference was observed between the liver and kidney. The concentration of zinc and calcium decreased in the kidneys and liver. Conclusion. Changes in calcium and zinc, accompanied by elevated levels of cadmium in the liver and kidneys, suggest that cadmium may interfere with the biological processes in which these elements are involved.

The Risk Factors of Blood Cadmium Elevation in Chronic Kidney Disease

Low-level cadmium exposure has adverse effects on chronic kidney disease (CKD); however, the risk factors for elevated blood cadmium levels (BCLs) have not been studied in CKD. We conducted a cross-sectional investigation in 200 CKD patients and stratified them by the tertiles of BCL to compare their demographic, environmental, and biochemical data. The factors associated with BCL were identified, and their effects were examined in subgroups. In the analyses, female sex, smoking, and CKD stage 5D were associated with high BCL, and statin was inversely correlated with BCL (odds ratio [95% confidence interval, CI], 6.858 [2.381–19.746], p < 0.001, 11.719 [2.843–48.296], p = 0.001, 30.333 [2.252–408.520], p = 0.010, and 0.326 [0.122–0.873], p = 0.026; deviations of BCL [nmol/L, 95% CI], 2.66 [1.33–4.00], p < 0.001, 3.68 [1.81–5.56], p < 0.001, 3.38 [0.95–5.82], p = 0.007, and −2.07 [−3.35–−0.78], p = 0.002). These factors were also independently correlated with BCL in subgroups, including non-dialysis CKD, hypertensive patients, non-smokers, and male patients. In conclusion, female sex, smoking, and CKD stage 5D were the major risk factors for elevated BCL; additionally, statins were negatively associated with BCL in CKD.

Association of plasma lead, cadmium, and selenium levels with hearing loss in adults: NHANES 2011-2012

To determine the association between hearing loss and environmental lead, cadmium, and selenium exposure, a total of 1503 American adults from National Health and Nutrition Examination Survey (NHANES) (2011∼2012) were assessed. The average of 4 audiometric frequencies (0.5, 1, 2, and 4 kHz) was used to identify speech-frequency hearing loss (SFHL), while the average of 3 audiometric frequencies (3, 4, and 6 kHz) was used to identify high-frequency hearing loss (HFHL). HFHL adjusted Odds ratios (ORs) determined by comparing the highest and lowest blood lead and cadmium quartiles were 1.98 (95%CI: 1.27, 3.10) and 1.81 (95%CI: 1.13, 2.90), respectively. SFHL was significant associated with blood cadmium with the OR = 2.42 for the highest quartile. When further stratified by age, this association appeared to be limited to adults aged 35-52 years. After stratified by gender, except for lead and cadmium, we observed that blood selenium showed a dose-dependent association with SFHL in men. In women, only cadmium showed a dose-dependent association with speech and high frequency hearing loss. Hearing loss was positively associated with blood levels of lead and cadmium. Additionally, our study provided novel evidence suggesting that excessive selenium supplement would increase SFHL risk in men.

Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease

Background and Objectives: chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and a history of exposure to noxious stimuli. Cigarette smoking is the most important causal factor for developing COPD. Cadmium, a minor metallic element, is one of the main inorganic components in tobacco smoke. Inhaled cadmium was associated with a decline in lung function, gas exchange impairment, and the development of obstructive lung disease. Patients with COPD who had oxygen desaturation during the 6-min walk test (6MWT) had a significantly worse prognosis than non-desaturation in COPD patients. Nonetheless, few studies have addressed the influence of blood cadmium levels on exercise-induced oxygen desaturation in COPD patients. Our objective was to assess the potential impact of blood cadmium levels on oxygen desaturation during the 6MWT among COPD patients. Materials and Methods: we performed a retrospective analysis of patients with COPD who were examined for blood cadmium levels in a tertiary care referral center in Taiwan, between March 2020 and May 2021. The 6-min walk test was performed. Normal control subjects who had no evidence of COPD were also enrolled. Results: a total of 73 COPD patients were analyzed and stratified into the high-blood cadmium group (13 patients) and low-blood cadmium group (60 patients). A total of 50 normal control subjects without a diagnosis of COPD were enrolled. The high-blood cadmium group had a significantly higher extent of desaturation than the low-blood cadmium group. The frequency of desaturation during 6MWT revealed a stepwise-increasing trend with an increase in blood cadmium levels. A multivariable logistic regression model revealed that blood cadmium levels were independently associated with desaturation during the 6MWT (odds ratio 12.849 [95% CI 1.168–141.329]; p = 0.037). Conclusions: our findings indicate that blood cadmium levels, within the normal range, were significantly associated with desaturation during 6MWT in patients with COPD.